Launch Diagnostics has increased its molecular diagnostic solution for SARS-CoV-2 with the addition of the Bosphore Novel Coronavirus (2019-nCoV) Detection kit v4 which is capable of detecting three different genes of SARS-CoV-2 in a single mix and the Bosphore SARS-CoV/Flu/RSV Panel kit.
Both assays are compatible with many open system platforms.
To complete the molecular portfolio, AmpliRun and AmpiRun Total molecular controls from Vircell are external quality controls for nucleic acid detection.
